[PHASE1] A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects

Part of

Predictive Modeling Of Chronic Liver And Metabolic Diseases